Biondvax Pharmaceuticals (BVXV) Earnings

Mar 28Confirmed
Aug 2021
Nov 2021
Q4 2021
Mar 2022
-2.7
-1.8
-0.9
-0.01

Details

Expected EPS
-0.85
Actual EPS
-2.7
Surprise EPS
-1.85
Surprise Percent
-217.65%

Description

⁨Biondvax Pharmaceuticals⁩ (⁦BVXV⁩) has reported earnings of ⁦-2.7⁩ per share for ⁦null⁩.

0 Comments

Share your thoughts